文献速递肝病

乳糜泻患者坚持无麸质饮食时非酒精性脂肪性肝病风险增加:超越传统代谢因素

Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors.
PubMed 文献 · Aliment Pharmacol Ther · 2018-07-08

这项病例对照研究前瞻性纳入坚持无麸质饮食的乳糜泻门诊患者与对照各202例,按年龄、性别及代谢危险因素1:1匹配。乳糜泻组非酒精性脂肪性肝病(NAFLD)粗患病率为34.7%,对照组为21.8%(P=0.006);校正后乳糜泻组NAFLD风险升高(调整比值比=2.90,95%置信区间:1.64-5.15,P<0.001),非超重乳糜泻患者风险更高(调整比值比=5.71,95%置信区间:2.30-14.19,P<0.001)。

要点

  • 坚持无麸质饮食的乳糜泻患者NAFLD粗患病率为34.7%,对照组为21.8%(P=0.006)。
  • 校正代谢因素后乳糜泻组NAFLD风险升高,调整比值比=2.90(95%置信区间:1.64-5.15,P<0.001)。
  • 非超重乳糜泻患者NAFLD风险更高,调整比值比=5.71(95%置信区间:2.30-14.19,P<0.001)。

核心结论

  • 超过三分之一的坚持无麸质饮食的乳糜泻患者合并NAFLD,风险约为一般人群的三倍。
  • 作者建议采用个体化饮食指导帮助合并NAFLD的乳糜泻患者实现适当营养摄入,同时降低长期肝脏相关事件风险。

研究设计与样本

  • 病例对照研究,前瞻性纳入坚持无麸质饮食的乳糜泻门诊患者与对照,按年龄、性别及代谢危险因素(超重、糖尿病、总胆固醇、甘油三酯)1:1匹配。
  • 共比较202例乳糜泻患者与202例对照,NAFLD依据欧洲肝脏研究学会标准诊断。

主要发现

  • 乳糜泻组NAFLD粗患病率为34.7%,对照组为21.8%(P=0.006)。
  • 二元逻辑回归证实乳糜泻组NAFLD风险升高,调整比值比=2.90(95%置信区间:1.64-5.15,P<0.001)。
  • 非超重乳糜泻患者NAFLD相对风险更高,调整比值比=5.71(95%置信区间:2.30-14.19,P<0.001)。

临床怎么用

  • 作者建议采用个体化饮食指导帮助合并NAFLD的乳糜泻患者实现适当营养摄入,同时降低长期肝脏相关事件风险。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A gluten-free diet (GFD) is known to be associated with altered macronutrient intake and metabolic syndrome. Nonalcoholic fatty liver disease (NAFLD) is the hepatic hallmark of metabolic syndrome. The risk of NAFLD in patients with coeliac disease (CD) adhering to a GFD remains to be fully investigated; in particular, data from real-life clinical settings are lacking. AIM: To assess the prevalence and relative risk of NAFLD in CD patients treated with a GFD. METHODS: Case-control study, with prospective enrolment of CD outpatients following a GFD and controls. Patients were matched for demographic characteristics (age and gender) and metabolic risk factors (overweight, diabetes mellitus, total cholesterol, and triglycerides) using a 1:1 ratio. NAFLD was diagnosed according to the European Association for the Study of the Liver criteria. RESULTS: 202 CD patients and 202 controls were compared. The raw prevalence of NAFLD was 34.7% and 21.8% in the CD and control group, respectively (P = 0.006). Binary logistic regression confirmed an increased risk of NAFLD in the CD group (adjusted odds ratio = 2.90, 95% confidence interval: 1.64-5.15, P < 0.001). Additionally, the relative risk for NAFLD was notably higher in non-overweight CD patients (adjusted odds ratio = 5.71, 95% confidence interval: 2.30-14.19, P < 0.001). CONCLUSIONS: More than one-third of CD patients adhering to a GFD had concurrent NAFLD, accounting for a three-fold increased risk compared to the general population. Dietary advice provided using a patient-tailored approach should assist CD patients with NAFLD in achieving an appropriate nutritional intake whilst reducing the risk of long-term liver-related events.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Tovoli F, Negrini G, Farì R, et al. Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. Aliment Pharmacol Ther. 2018. PMID: 29984415. doi:10.1111/apt.14910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。